WG
TEVA icon

Winton Group’s Teva Pharmaceuticals TEVA Stock Holding History

Winton Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-80,079
Closed -$730K – 1065
2022
Q4 		$730K Buy
+80,079
New +$699K 0.05% 514
2022
Q3 		– Sell
-35,901
Closed -$270K – 1083
2022
Q2 		$270K Buy
35,901
+13,406
+60% +$117K 0.01% 826
2022
Q1 		$211K Buy
+22,495
New +$188K 0.01% 902
2019
Q1 		– Sell
-260,996
Closed -$4.03M – 1178
2018
Q4 		$4.03M Buy
+260,996
New +$5.35M 0.09% 275

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Winton Group's TEVA Position: Q1 2023 in Review

Winton Group sold out of Teva Pharmaceuticals (TEVA) in Q1 2023, closing a stake of 80,079 shares — an estimated $730K sold.

Winton Group first reported a position in TEVA in Q4 2018 and held it in 4 quarters. The position peaked at $4.03M in Q4 2018. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2023.

  • Winton Group reported no remaining Teva Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Winton Group sold 80,079 Teva Pharmaceuticals shares in Q1 2023, an estimated $730K.
  • Winton Group first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Winton Group's Teva Pharmaceuticals position peaked at $4.03M in Q4 2018.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2023.

Based on Winton Group's 13F filing for Q1 2023, filed 12 May 2023.